The longitudinal muscle layer in gut is the functional opponent to the circular muscle layer during peri- 
Introduction
Gastrointestinal motility requires coordinated activity of the two muscular layers of the gut, the circular muscle layer and the longitudinal muscle layer (1) (2) (3) (4) . The circular muscle layer consists of muscle cells oriented around the circumference of the gut lumen, forming adjacent rings of muscle that extend throughout the gut. Upon local activation of these cells, the circular muscle tissue contracts, and these muscular rings decrease their diameter and therefore the caliber of the gut lumen. The longitudinal muscle layer is comprised of cells oriented along the long axis of the gut, parallel to the overall direction of the movement of contents. Upon local activation of the peristaltic reflex, contraction of the longitudinal muscle causes the gut to shorten while the relaxation of the circular muscle layer causes an increase in the diameter of the lumen. Thus, the two muscular layers are not normally activated at the same location simultaneously (5-7); however, when these opposing actions occur in the longitudinal and circular muscle layers at contiguous locations, the contents of the lumen can be propelled distally in a controlled fashion. Functional differences are evident between the two muscle layers and reflect distinct receptor expression, calcium handling, and signaling pathways involved in muscle contraction (7) (8) (9) (10) (11) (12) (13) (14) .
Muscle activity is driven by the interaction of the proteins actin and myosin, which facilitates the inherent ATPase activity of the heavy chains of myosin. The phosphorylation of the 20 kDa myosin regulatory light chain (MLC 20 ) at a serine residue at position 19 is sufficient to cause cross-bridge formation and cycling, ATP hydrolysis, and muscle contraction (15, 16) . Myosin light chain kinase (MLCK) is a dedicated serine-threonine kinase that has MLC 20 as its sole substrate. Upon binding with the calcium-calmodulin complex, MLCK phosphorylates MLC 20 at serine 19 (15) (16) (17) . Myosin light chain phosphatase (MLCP) is the opposing enzyme to MLCK, removing the phosphate from Serine 19 on MLC 20 . It is a trimer composed of protein phosphatase 1c-delta, the myosin phosphatase target subunit 1 (MYPT1), and a small 20kDa subunit MP20. MYPT1 targets the phosphatase subunit to MLC 20 , while increasing the specificity of PP1c-delta through a conformational change that occurs when bound to MYPT1. The MP20 subunit is of unknown function (18, 19) .
Many studies have shown that MLC 20 phosphorylation can be regulated, either directly or through the regulation of MLCP activity and associated proteins, by several other kinases including Rho kinase, ERK1/2, CaMKII, PAK and CaMKK (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . This regulation is important during the agonist-induced sustained contraction as MLCK activity is transient and in synchronization with the transient nature of increase in Ca 2+ levels (16, 36, 37) . The activity of MLCK itself can be affected by its phosphorylation at several site(s); kinases that phosphorylate can increase or decrease MLCK activity, and may do so by either altering the rate of enzyme activity or the affinity of MLCK for Ca-CaM (38-42).
Our previous studies have shown that in both circular and longitudinal intestinal smooth muscle, contraction in response to G protein-coupled receptor agonists is biphasic (36, 37) . However, the mechanisms that mobilize Ca 2+ for initial contraction and regulate MLCP activity for sustained contraction are distinct in these types of muscle (8, 13) . The aim of the present study is to characterize the role of various kinases that are activated in response to contractile agonists in the regulation of MLCK activity and muscle contraction in response to muscarinic receptor activation in innervated longitudinal muscle strips. Our results demonstrate a distinct pattern of regulation. Similar to studies in isolated muscle cells, inhibition of both Rho kinase and ERK1/2 leads to diminished contraction in innervated muscle strips, but unlike isolated cells, inhibition of CaMKK/AMPK and CaMKII also diminished contraction. 
Materials and Methods

Materials
Animal Preparation
Rats were euthanized by CO 2 asphyxiation under approved protocols. 
Muscle Strip Preparation
Strips destined for recordings of contractile behavior were tied at both ends with surgical silk so that one end had a simple loop for attachment to a glass hook and the other end had a length of silk tied to a brass ring.
The strip was then placed in a vertical orientation with the loop secured to a glass hook and the brass ring to a Model FT03C Force Transducer (Grass Technologies, Quincy, MA 
Isometric force measurement
Force experiments were conducted in the following manner. Following hanging of the strip and submersion in the organ bath, strips were subjected to approximately 1 gram of pre-tension via the mounting rack-andpinion. Strips were allowed to equilibrate for no less than 30 minutes before experiments were conducted and data collected. Exposure to inhibitors, blockers, and carbachol occurred within the organ bath. Concentrations were appropriate and in agreement with current literature and are noted in the results. Following an experiment, strip data were reviewed and analyzed from within the Polyview software suite. One way ANOVA and paired t-tests were conducted in GraphPad (GraphPad Software, La Jolla, CA), and significance set at P<0.05.
All tests of significance were done by comparison of raw data between control and experimental groups.
Data Analysis
Contractile data was viewed from three perspectives as to the effects of kinase inhibition: changes to basal tone upon kinase inhibitor administration, peak contractile amplitude following agonist exposure, and as area under the curve measurement. The latter was used to quantify the contraction as viewed during the first two minutes of the contraction in an effort to determine differences in force development/decay. All numerical values are expressed as mean ± S.E.M.
Basal tension was measured as the mean tension during a 3 minute period following at least 30 min of equilibration (control conditions) or 10 min of inhibitor incubation (basal recording obtained during the interval proceeding carbachol administration). Such measurements were made in multiple strips from multiple animals, and paired t-tests conducted to determine a significant effect. Peak contraction (amplitude) was defined to be the greatest amplitude of tone above basal during the two minute period following agonist administration.
This two minute period is taken to begin when the contractile response began to rise from basal value. Area under curve (AUC) for first two minutes of exposure reflects the development and maintenance of the tension and was expressed as gram-seconds.
Kinase Assay
Activity of MLCK activity was measured by an immunokinase assay as described previously (37, 43, 44) .
One hundred µg of protein was transferred from the supernatant of prepared tissue sample to a designated tube, 
Results
Muscarinic m3 receptor-mediated contraction
Longitudinal muscle strips exposed to carbachol (CCh) at concentrations of 10 nM, 1 µM, and 100 µM Repeated measurements of peak contraction and area under the curve in response to 1 µM CCh were conducted on strips following wash for 15 min in Krebs buffer and contractions were calculated as percentage of initial contraction before wash. There were no significant differences in either peak contraction or AUC with repeated measurements. Following a 15 min incubation after initial contraction, peak contraction was 98.29% ± 3.99% (n=13, 5 animals) and the AUC for 2 min was 102.1% ± 1.88% (n=13, 5 animals) of the initial contraction ( Fig. 2A and 2B ).
Smooth muscle expresses both m2 and m3 muscarinic receptors (45) (46) (47) (48) . As shown previously in circular muscle, CCh-induced contraction in longitudinal muscle is mediated primarily by muscarinic m3 receptors.
Muscle strips were pretreated with m2 receptor antagonist, methoctramine (1 µM) or m3 receptor antagonist 4-DAMP (1 µM) and the response to 1 µM CCh was measured. Incubation with methoctramine caused no significant changes to peak contraction or AUC in response to CCh (P>0.05, n=7 from 4 animals). Incubation with 4-DAMP, however, abolished responses to CCh (Fig. 2) . These results indicate that contraction in response to CCh is mediated mainly by activation of m3 receptors.
To further examine the smooth muscle muscarinic m3 receptors, muscle strips were incubated with 1 μM tetrodotoxin (TTX), a Na + channel blocker, and the contractile response to different concentrations of CCh was measured. Consistent with the blockade of CCh-induced contraction with m3 receptor antagonist, incubation of muscle strips with 1 μM tetrodotoxin (TTX), had no significant changes to peak contraction or AUC in response to different concentrations of CCh (P>0.05, n=7 from 4 animals). Peak contractions in the presence of TTX exposure were 102.8% ± 5.98% of the control value at 1 μM CCh (n=7), 113.2 ± 8.6% at 10 μM CCh (n=7), and 110.5 ± 9.1% at 100 μM CCh (n=7) and the AUC were 112.1 ± 7.3% of the control value at 1 µM, Fig. 1 . Contractile response of longitudinal muscle strips to carbachol. Longitudinal muscle strips of rat colon were placed in an organ bath and subjected to 1 g of basal tension. After 30 min of equilibration, different concentrations of carbachol (CCh, 10 nM to 100 µM) was added. Contractile response with maximum force was measured as peak contraction (A) and total response for first 2 min, measured as area under curve (AUC), was considered as total contraction (B). Carbachol elicited dose-dependent increase in both peak and total contraction. Values are means ± SEM of 6-7 experiments and each experimental value was derived from several strips. **P<0.05 significant contraction.
110.4 ± 4.5% at 10 µM and 97.7 ± 8.3% at 100 µM CCh (n=7).
Regulation of CCh-induced contraction by kinases
Previous studies have shown that activation of m3 receptors leads to stimulation of various kinases such as Rho kinase, ERK1/2, CaMKII and AMPK and these kinases in turn, as shown in isolated cells, regulate phosphorylation of MLC 20 levels (37, 43, 44, 49) . To examine the role of these kinases, muscle strips were preincubated with inhibitors of Rho kinase (Y27632), ERK1/2 (PD98059), CaMKII (KN62) or CaMKK (STO-609) and the response to CCh was measured.
1) Regulation by Rho kinase
Treatment of muscle strips with Rho kinase inhibitor Y27632 (10 µM) for 10 min led to a significant decrease in basal tone from 0.82 ± 0.07 grams to 0.73 ± 0.06 grams (P<0.01, n=15). Y27632 also significantly reduced contraction in response to different concentrations of CCh. Peak contractions (in grams) for control (Fig. 4A) (Fig. 4B) .
The inhibitory effect of Y27632 in combination with PD98059 was not significantly greater than the effect obtained with PD98059 alone: 1.17 ± 0.19 grams for 1 µM CCh, 0.96 ± 0.14 grams CCh plus PD98059 alone (P<0.05), 0.85 ± 0.13 grams for CCh plus PD98059 and Y27632 (P<0.05) (Fig. 5 ). (Fig. 6A) . A similar inhibition of contraction was also observed when AUC was calculated and the values (in gram-seconds) Fig. 3 . Effect of Rho kinase inhibitor, Y27632, on carbachol-induced contraction. Longitudinal muscle strips of rat colon were placed in an organ bath and subjected to 1 g of basal tension. After 30 min of equilibration, strips were incubated for 15 min with the selective Rho kinase inhibitor Y27632 (10 µM) and then with different concentrations of CCh (10 nM to 100 µM). Contractile response with maximum force was measured as peak contraction (A) and total response for first 2 min, measured as area under curve (AUC), was considered as total contraction (B Longitudinal muscle strips of rat colon were placed in an organ bath and subjected to 1 g of basal tension. After 30 min of equilibration, strips were incubated for 15 min with the selective ERK1/2 inhibitor PD98059 (10 µM) alone or in combination with Rho kinase inhibitor Y27632 (10 µM) and then with CCh (1 µM). Contractile response was measured as peak contraction. Values are means ± SEM of 4-7 experiments and each experimental value was derived from several strips. **P<0.05 significant inhibition of CCh-induced contraction.
n=7), and 68.36 ± 9.72 for CCh plus STO-609 and Y27632 (P<0.05, n=7) (Fig. 7B) . Thus, there is a significant (P<0.05 for both peak and AUC contraction) additive effect of CaMKK inhibition and Rho Kinase inhibition on both peak contraction and AUC.
4) Regulation by CaMKII
Treatment of muscle strips with CaMKII inhibitor KN-62 (10 µM) for 10 min caused a significant decrease in basal tone from 0.61 ± 0.07 grams to 0.53 ± 0.07 grams (P<0.05). KN-62 also significantly reduced (Fig. 8B) . Longitudinal muscle strips of rat colon were placed in an organ bath and subjected to 1 g of basal tension. After 30 min of equilibration, strips were incubated for 15 min with the selective CaMKII inhibitor KN62 (10 µM) alone or in combination with Rho kinase inhibitor Y27632 (10 µM) and then with CCh (1 µM). Contractile response was measured as peak contraction (A) and total response for first 2 min, measured as area under curve (AUC), was considered as total contraction (B). Values are means ± SEM of 8 experiments and each experimental value derived from several strips. **P<0.05 significant inhibition of CCh-induced contraction.
The inhibitory effect of Y27632 in combination with KN-62 was significantly greater than the effect obtained with KN-62 alone. Peak contractions were 0.92 ± 0.09 grams for CCh alone, 0.60 ± 0.05 grams for CCh plus KN-62 (P<0.05), and 0.36 ± 0.06 grams for CCh plus KN-62 and Y27632 (P<0.01) (Fig. 9A) . For AUC the values (in grams-seconds) were 80.97 ± 11.84 for CCh alone, 51.43 ± 4.00 for CCh plus KN-62 (P<0.05, n=8), and 34.70 ± 3.18 for CCh plus KN-62 and Y27632 (P<0.05, n=8) (Fig. 9B) . Thus, there is a significant (P<0.05
for both peak and AUC contraction) additive effect of CaMKII inhibition and Rho Kinase inhibition on both peak contraction and AUC.
5) Effect of kinase inhibitors on MLCK activity
The effect of each kinase inhibitor was examined to determine if it had a direct effect on MLCK activity induced by 1 µM CCh. CCh caused a significant increase in MLCK activity (65 ± 18% above basal). There was no significant effect of any of the kinase inhibitors on the MLCK kinase activity induced by 1 µM CCh (P>0.05 vs 1 µM CCh alone for each kinase) (Fig. 10 ).
Discussion
Gastrointestinal motility is mediated by the coordinated contractile activity of smooth muscle cells of both circular and longitudinal muscle layer. The main excitatory neurotransmitters in the gastrointestinal tract are acetylcholine and substance P (1-3) . This study demonstrated that contraction in longitudinal muscle strips, both peak contraction and total contraction (measured as AUC), in response to the acetylcholine mimetic, carbachol, was solely dependent on activation of m3 receptors. Similar m3 receptor-dependent contraction was also reported in smooth muscle from circular muscle layer (37) . The results are consistent with the concept that m3 receptors are known to play a dominant role in eliciting smooth muscle contraction and m2 receptors are considered to play a minor role despite their abundant expression (45) (46) (47) (48) 50) . Physiologically in vivo activation of the m2 receptor augments smooth muscle contractions mediated by m3 receptors. This is consistent with the concept of the conditional role of the m2 receptors in the smooth muscle (45, 46) . Studies by Unno et al. (48), using m2 and m3 receptor knockout mice and pertussis toxin (PTx) to block m2-mediated contractions, have demonstrated that both m2 and m3 receptor activation induces ileal muscle contraction and the contribution of m2 receptors to contraction depends on the concentration of carbachol; at less than 1 µM carbachol, nearly 80% of the contractions are PTx sensitive and at concentrations more than 10 µM carbachol, PTx had no significant effect suggesting that the contribution of m2 receptors to CCh-induced contraction is significant only at low CCh concentrations and decreases with increasing concentrations of CCh. The notion that the effect of CCh in innervated longitudinal muscle strips could be due to activation of neuronal receptors was excluded as blockade of neuronal activation with tetrodotoxin had no effect on CCh-induced peak and total contraction. The involvement of ERK1/2 was shown to be dependent on the type of smooth muscle and agonist. In rat aorta, PD98059 had no effect on K + -induced contraction, but inhibited lysophosphtidylcholine-induced augmentation of K + -induced contraction (61) . In lower esophageal sphincter of rat or cat, PD98059 reduced agonist-induced contraction (62, 63) . In swine carotid arteries, PD98059 had no effect on histamine-induced contraction (64), whereas in ferret aorta PD98059 had no effect on K + -induced contraction, but significantly inhibited phenylephrine-induced contraction in the absence, but not in the presence of extracellular Ca 2+ (59 (32, 43) .
STO609, an inhibitor of CaMKKβ (66), blocked muscarinic receptor-induced phosphorylation of AMPK and MLCK resulting in attenuation of AMPK activity and augmentation of MLCK activity, MLC 20 phosphorylation and muscle contraction in circular muscle. In contrast, in longitudinal strips as shown in the present study, inhibition of CaMKK activity was found to reduce peak and total contraction but had no effect on MLCK activity. The distinct role of CaMKKβ in the regulation of MLCK activity and muscle contraction in the innervated muscle strips compared to isolated muscle awaits further work.
Inhibition of another Ca 2+ /CaM-dependent enzyme CaMKII also reduced CCh-induced peak and total contraction. These results are also in conflict with the previous studies in tracheal smooth muscle demonstrating that CaMKII phosphorylates MLCK and inhibits its activity by decreasing affinity for Ca 2+ /CaM (38). Kim et al, however, demonstrated direct phosphorylation of MLC 20 with CaMKII activation in ferret aorta. CaM-KII also has positive modulatory effects on Ca 2+ channels that may lead to increase in contraction. Another possibility could be inhibition of ERK1/2 activity and ERK1/2-dependent contractile process as CaMKII was shown to be an upstream effector of ERK1/2 (58, 67) . Thus blockade of CaMKII would affect contraction in a manner similar to ERK1/2 inhibition.
